Healthcare provider profile · identity verified

Darshna N Patel

Family Practice · AUGUSTA, GA · NPI 1033748819

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	354	154
Amlodipine Besylate	Amlodipine Besylate	203	87
Levothyroxine Sodium	Levothyroxine Sodium	175	61
Fluticasone Propionate	Fluticasone Propionate	156	78
Lisinopril	Lisinopril	148	65
Losartan Potassium	Losartan Potassium	126	53
Tamsulosin Hcl	Tamsulosin Hcl	105	43
Gabapentin	Gabapentin	86	35
Hydrochlorothiazide	Hydrochlorothiazide	83	39
Metoprolol Succinate	Metoprolol Succinate	80	30
Pantoprazole Sodium	Pantoprazole Sodium	72	35
Albuterol Sulfate Hfa	Albuterol Sulfate	70	39
Omeprazole	Omeprazole	69	33
Atenolol	Atenolol	67	26
Trazodone Hcl	Trazodone Hcl	65	28
Ozempic	Semaglutide	63	16
Doxycycline Monohydrate	Doxycycline Monohydrate	62	48
Rosuvastatin Calcium	Rosuvastatin Calcium	62	30
Alendronate Sodium	Alendronate Sodium	59	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	58	14
Metformin Hcl Er	Metformin Hcl	58	24
Famotidine	Famotidine	55	27
Pradaxa	Dabigatran Etexilate Mesylate	55	20
Sertraline Hcl	Sertraline Hcl	52	24
Metoprolol Tartrate	Metoprolol Tartrate	51	19
Simvastatin	Simvastatin	51	23
Furosemide	Furosemide	48	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	20
Ibuprofen	Ibuprofen	43	24
Lorazepam	Lorazepam	41	12
Alvesco	Ciclesonide	40	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	34
Spiriva Respimat	Tiotropium Bromide	35	16
Acyclovir	Acyclovir	34	16
Escitalopram Oxalate	Escitalopram Oxalate	32	16
Jardiance	Empagliflozin	28	15
Metformin Hcl	Metformin Hcl	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	11
Carvedilol	Carvedilol	27	suppressed
Metronidazole	Metronidazole	27	19
Bupropion Xl	Bupropion Hcl	26	suppressed
Mupirocin	Mupirocin	26	15
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	25	25
Allopurinol	Allopurinol	25	16
Methocarbamol	Methocarbamol	24	11
Spironolactone	Spironolactone	24	11
Tramadol Hcl	Tramadol Hcl	23	suppressed
Breyna	Budesonide/Formoterol Fumarate	22	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	22	22
Duloxetine Hcl	Duloxetine Hcl	22	11
Meloxicam	Meloxicam	21	suppressed
Tadalafil	Tadalafil	21	suppressed
Betamethasone Valerate	Betamethasone Valerate	19	suppressed
Ciclopirox	Ciclopirox	19	suppressed
Glipizide	Glipizide	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Hydrocortisone	Hydrocortisone	17	13
Torsemide	Torsemide	17	suppressed
Lovastatin	Lovastatin	16	suppressed
Temazepam	Temazepam	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Naproxen	Naproxen	14	suppressed
Repatha Sureclick	Evolocumab	14	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	13
Potassium Chloride	Potassium Chloride	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Terazosin Hcl	Terazosin Hcl	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	11
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Alclometasone Dipropionate	Alclometasone Dipropionate	11	suppressed
Cefadroxil	Cefadroxil	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Nystatin	Nystatin	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error